In a double-blind study with a 24-week duration (458), daily treatment with 100 μg PTH (1-84) reduced the daily need of calcium and active vitamin D supplementation by 75% and 73%, respectively, although hypercalcemia occurred frequently during the period of down-titration of the supplements. Here, PTH is linked to hypercalcemia disease.